News Sentiment

CRDF sentiment intelligence

Cardiff Oncology Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.88 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-33.8% over one week, -27.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Cardiff Oncology (CRDF) Proxy filing Summary

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -33.8% Price reacting lower
Trend fit Trend inactive -27.3% over four weeks
Fair value -65.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 34
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 10
TradingView 8
simplywall.st 4
Investing.com 3
GlobeNewswire 3
Finviz 3
www.marketscreener.com 3

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 14
Analyst action 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
www.marketscreener.com Direct company coverage

Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Completeness Index

Cardiff Oncology, Inc. (NasdaqCM:CRDF) has been removed from the Russell Small Cap Completeness Index. This news follows a series of announcements indicating the company's removal from several other Russell benchmarks, including the Russell 2500 Growth, Russell 2000 Value, Russel

Tone
Negative 29/100
Event
Market update
Published
29 Jun 2026 09:41
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Growth Benchmark

Cardiff Oncology, Inc. (NasdaqCM: CRDF) has been removed from the Russell 2000 Growth Benchmark index. This news follows a series of recent changes in the company's index inclusions, as well as several analyst downgrades and financial reports highlighting its performance and stra

Tone
Negative 29/100
Event
Analyst action
Published
29 Jun 2026 07:40
Source
www.marketscreener.com